| For: | Wu CP, Jiang JT, Tan M, Zhu YB, Ji M, Xu KF, Zhao JM, Zhang GB, Zhang XG. Relationship between co-stimulatory molecule B7-H3 expression and gastric carcinoma histology and prognosis. World J Gastroenterol 2006; 12(3): 457-459 [PMID: 16489649 DOI: 10.3748/wjg.v12.i3.457] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i3/457.htm |
| Number | Citing Articles |
| 1 |
Sabine Groeger, H. P. Howaldt, H. Raifer, S. Gattenloehner, T. Chakraborty, J. Meyle. Oral Squamous Carcinoma Cells Express B7-H1 and B7-DC Receptors in Vivo. Pathology & Oncology Research 2017; 23(1) doi: 10.1007/s12253-016-0100-7
|
| 2 |
Christina Tekle, Marit Kveine Nygren, Yih‐Wen Chen, Indrejit Dybsjord, Jahn Marthin Nesland, Gunhild Mari Mælandsmo, Øystein Fodstad. B7‐H3 contributes to the metastatic capacity of melanoma cells by modulation of known metastasis‐associated genes. International Journal of Cancer 2012; 130(10) doi: 10.1002/ijc.26238
|
| 3 |
Luana Calabrò, Luca Sigalotti, Ester Fonsatti, Erica Bertocci, Anna Maria Di Giacomo, Riccardo Danielli, Ornella Cutaia, Francesca Colizzi, Alessia Covre, Luciano Mutti, Pier Giorgio Natali, Michele Maio. Expression and regulation of B7‐H3 immunoregulatory receptor, in human mesothelial and mesothelioma cells: Immunotherapeutic implications. Journal of Cellular Physiology 2011; 226(10) doi: 10.1002/jcp.22600
|
| 4 |
Xiao-Juan Chen, Jin Shen, Guang-Bo Zhang, Wei-Chang Chen. B7-H6 Protein Expression has no Prognostic Significance in Human Gastric Carcinoma. Pathology & Oncology Research 2014; 20(1) doi: 10.1007/s12253-013-9686-1
|
| 5 |
Hans-Peter Gerber, Peter D Senter, Iqbal S Grewal. Antibody drug-conjugates targeting the tumor vasculature. mAbs 2009; 1(3) doi: 10.4161/mabs.1.3.8515
|
| 6 |
Aleksander Kielbik, Veronika Bahlinger, Christian Schürch, Maria Luisa Barcena, Olesya Vakhrusheva, Anita Thomas, Igor Tsaur, Jonas Heitmann, Helmut Salih, Ilona Hagelstein. B7-H3 (CD276) as Target for T Cell-Based Bispecific Antibody Therapy of Penile Cancer. ImmunoTargets and Therapy 2026; doi: 10.2147/ITT.S577364
|
| 7 |
Masaaki Hashiguchi, Yuka Inamochi, Shoya Nagai, Noriko Otsuki, Jinhua Piao, Hiroko Kobori, Yumiko Kanno, Hidefumi Kojima, Tetsuji Kobata, Miyuki Azuma. Human B7-H3 binds to Triggering receptor expressed on myeloid cells-like transcript 2 (TLT-2) and enhances T cell responses. Open Journal of Immunology 2012; 2(01) doi: 10.4236/oji.2012.21002
|
| 8 |
Tai-Wei Sun, Qiang Gao, Shuang-Jian Qiu, Jian Zhou, Xiao-Ying Wang, Yong Yi, Jie-Yi Shi, Yong-Feng Xu, Ying-Hong Shi, Kang Song, Yong-Sheng Xiao, Jia Fan. B7-H3 is expressed in human hepatocellular carcinoma and is associated with tumor aggressiveness and postoperative recurrence. Cancer Immunology, Immunotherapy 2012; 61(11) doi: 10.1007/s00262-012-1278-5
|
| 9 |
JING SUN, YONG MAO, YANG-QIN ZHANG, YUN-DI GUO, CHUAN-YONG MU, FENG-QING FU, XUE-GUANG ZHANG. Clinical significance of the induction of macrophage differentiation by the costimulatory molecule B7-H3 in human non-small cell lung cancer. Oncology Letters 2013; 6(5) doi: 10.3892/ol.2013.1586
|
| 10 |
WEI DAI, GENHAI SHEN, JIANPING QIU, XIN ZHAO, QUANGEN GAO. Aberrant expression of B7-H3 in gastric adenocarcinoma promotes cancer cell metastasis. Oncology Reports 2014; 32(5) doi: 10.3892/or.2014.3405
|
| 11 |
Gen Li, Yanchun Quan, Fengyuan Che, Lijuan Wang. B7-H3 in tumors: friend or foe for tumor immunity?. Cancer Chemotherapy and Pharmacology 2018; 81(2) doi: 10.1007/s00280-017-3508-1
|
| 12 |
Lihua Xu, Xiangmin Ding, Huo Tan, Jianjun Qian. Correlation between B7-H3 expression and matrix metalloproteinases 2 expression in pancreatic cancer. Cancer Cell International 2013; 13(1) doi: 10.1186/1475-2867-13-81
|
| 13 |
Martin Loos, Dennis M Hedderich, Malte Ottenhausen, Nathalia A Giese, Melanie Laschinger, Irene Esposito, Jörg Kleeff, Helmut Friess. Expression of the costimulatory molecule B7-H3 is associated with prolonged survival in human pancreatic cancer. BMC Cancer 2009; 9(1) doi: 10.1186/1471-2407-9-463
|
| 14 |
J. Louise Lines, Lorenzo F. Sempere, Thomas Broughton, Li Wang, Randolph Noelle. VISTA Is a Novel Broad-Spectrum Negative Checkpoint Regulator for Cancer Immunotherapy. Cancer Immunology Research 2014; 2(6) doi: 10.1158/2326-6066.CIR-14-0072
|
| 15 |
Yi Li, Jingjing Zhang, Sai Han, Qiuhong Qian, Qian Chen, Lu Liu, Youzhong Zhang. B7-H3 promotes the proliferation, migration and invasiveness of cervical cancer cells and is an indicator of poor prognosis. Oncology Reports 2017; 38(2) doi: 10.3892/or.2017.5730
|
| 16 |
Yixin Hu, Xin Lv, Yujie Wu, Ji Xu, Lingling Wang, Weifeng Chen, Wei Zhang, Jianyong Li, Sujiang Zhang, Hongxia Qiu. Expression of costimulatory molecule B7-H3 and its prognostic implications in human acute leukemia. Hematology 2015; 20(4) doi: 10.1179/1607845414Y.0000000186
|
| 17 |
Mao Yang, Simeng Tian, Zhoujun Lin, Zhenkun Fu, Chenggang Li. Costimulatory and coinhibitory molecules of B7-CD28 family in cardiovascular atherosclerosis: A review. Medicine 2022; 101(45) doi: 10.1097/MD.0000000000031667
|
| 18 |
Vibeke A Ingebrigtsen, Kjetil Boye, Jahn M Nesland, Arild Nesbakken, Kjersti Flatmark, Øystein Fodstad. B7-H3 expression in colorectal cancer: associations with clinicopathological parameters and patient outcome. BMC Cancer 2014; 14(1) doi: 10.1186/1471-2407-14-602
|
| 19 |
I Yamato, M Sho, T Nomi, T Akahori, K Shimada, K Hotta, H Kanehiro, N Konishi, H Yagita, Y Nakajima. Clinical importance of B7-H3 expression in human pancreatic cancer. British Journal of Cancer 2009; 101(10) doi: 10.1038/sj.bjc.6605375
|
| 20 |
Feifei Wang, Guoyan Wang, Tongshen Liu, Guohua Yu, Guangbo Zhang, Xiying Luan. B7-H3 was Highly Expressed in Human Primary Hepatocellular Carcinoma and Promoted Tumor Progression. Cancer Investigation 2014; 32(6) doi: 10.3109/07357907.2014.909826
|
| 21 |
Hong Xu, Irene Y. Cheung, Hong-Fen Guo, Nai-Kong V. Cheung. MicroRNA miR-29 Modulates Expression of Immunoinhibitory Molecule B7-H3: Potential Implications for Immune Based Therapy of Human Solid Tumors. Cancer Research 2009; 69(15) doi: 10.1158/0008-5472.CAN-08-4517
|
| 22 |
Natalia Martin-Orozco, Chen Dong. Inhibitory costimulation and anti-tumor immunity. Seminars in Cancer Biology 2007; 17(4) doi: 10.1016/j.semcancer.2007.06.003
|
| 23 |
Yecheng Li, Xiaodong Yang, Yong Wu, Kui Zhao, Zhenyu Ye, Junjia Zhu, Xiaohui Xu, Xin Zhao, Chungen Xing. B7-H3 promotes gastric cancer cell migration and invasion. Oncotarget 2017; 8(42) doi: 10.18632/oncotarget.17847
|
| 24 |
Jiayu Liang, Zhihong Liu, Tianjiao Pei, Yingming Xiao, Liang Zhou, Yongquan Tang, Chuan Zhou, Kan Wu, Fuxun Zhang, Fan Zhang, Xiaoxue Yin, Ni Chen, Xin Wei, Yiping Lu, Yuchun Zhu. Clinicopathological and Prognostic Characteristics of CD276 (B7-H3) Expression in Adrenocortical Carcinoma. Disease Markers 2020; 2020 doi: 10.1155/2020/5354825
|
| 25 |
Taslima T. Lina, Jazmin Gonzalez, Irina V. Pinchuk, Ellen J. Beswick, Victor E. Reyes. Helicobacter pylori Elicits B7-H3 Expression on Gastric Epithelial Cells: Implications in Local T Cell Regulation and Subset Development During Infection. Clinical Oncology and Research 2019; doi: 10.31487/j.COR.2019.05.05
|
| 26 |
CHUANYONG LIU, JIE LIU, JIE WANG, YAN LIU, FANG ZHANG, WENLI LIN, AIQIN GAO, MEILI SUN, YUNSHAN WANG, YUPING SUN. B7-H3 expression in ductal and lobular breast cancer and its association with IL-10. Molecular Medicine Reports 2013; 7(1) doi: 10.3892/mmr.2012.1158
|
| 27 |
. 2011; doi: 10.70675/87ebabd9z6c47z43efzb34cz2665c766473d
|
| 28 |
Soorya Suresh, Surabhi Maurya, Kajal Singh, Kapil Sharma, Subhechchha Bar, Aastha Dagar, Vivek Uttam, Sandeep Singh, Farman Ahmad, Manju Jain, Raj Kumar, Gautam Sethi, Aklank Jain. Drug discovery strategies targeting B7-H3 (CD276) in lung and gastric cancers: From biological validation to next-generation small molecules, biologics and cell-based immunotherapies. Drug Discovery Today 2026; 31(6) doi: 10.1016/j.drudis.2026.104814
|
| 29 |
Joanne Leung, Woong-Kyung Suh. The CD28-B7 Family in Anti-Tumor Immunity: Emerging Concepts in Cancer Immunotherapy. Immune Network 2014; 14(6) doi: 10.4110/in.2014.14.6.265
|
| 30 |
Ioannis-Alexios Koumprentziotis, Charalampos Theocharopoulos, Dimitra Foteinou, Erasmia Angeli, Amalia Anastasopoulou, Helen Gogas, Dimitrios C. Ziogas. New Emerging Targets in Cancer Immunotherapy: The Role of B7-H3. Vaccines 2024; 12(1) doi: 10.3390/vaccines12010054
|
| 31 |
Margaret K. Callahan, Jedd D. Wolchok, James P. Allison, Padmanee Sharma. Cancer Immunotherapy. 2013; doi: 10.1007/978-1-4614-4732-0_8
|
| 32 |
Fangfei Li, Xuan Du, Mei Han, Xiaoying Feng, Chunmeng Jiang. Targeting ETHE1 inhibits tumorigenesis in vitro and in vivo by preventing aerobic glycolysis in gastric adenocarcinoma cells. Oncology Letters 2025; 29(6) doi: 10.3892/ol.2025.15032
|
| 33 |
Kit Kitichotkul, Nirush Lertprasertsuke, Sompid Kintarak, Surawut Pongsiriwet, Warit Powcharoen, Anak Iamaroon. Expression of PD-L1 is HPV/P16-independent in oral squamous cell carcinoma. Heliyon 2022; 8(10) doi: 10.1016/j.heliyon.2022.e10667
|
| 34 |
Ronald L Koretz. Parenteral nutrition and urban legends. Current Opinion in Gastroenterology 2008; 24(2) doi: 10.1097/MOG.0b013e3282f43a9b
|
| 35 |
Sabine Groeger, Eugen Domann, Jose R. Gonzales, Trinad Chakraborty, Joerg Meyle. B7-H1 and B7-DC receptors of oral squamous carcinoma cells are upregulated by Porphyromonas gingivalis. Immunobiology 2011; 216(12) doi: 10.1016/j.imbio.2011.05.005
|
| 36 |
Baozhu Huang, Liqun Luo, Jun Wang, Bailin He, Rui Feng, Na Xian, Qiong Zhang, Lieping Chen, Gangxiong Huang. B7-H3 specific T cells with chimeric antigen receptor and decoy PD-1 receptors eradicate established solid human tumors in mouse models. OncoImmunology 2020; 9(1) doi: 10.1080/2162402X.2019.1684127
|
| 37 |
Lin Li, Siji Nian, Qin Liu, Bo Zhang, Wulemo Jimu, Chengwen Li, Zhanwen Huang, Qiaosen Hu, Yuanshuai Huang, Qing Yuan. Fully human anti-B7-H3 recombinant antibodies inhibited tumor growth by increasing T cell infiltration. International Immunopharmacology 2024; 132 doi: 10.1016/j.intimp.2024.111926
|
| 38 |
Peixin Dong, Ying Xiong, Junming Yue, Sharon J. B. Hanley, Hidemichi Watari. B7H3 As a Promoter of Metastasis and Promising Therapeutic Target. Frontiers in Oncology 2018; 8 doi: 10.3389/fonc.2018.00264
|
| 39 |
Sarah Bonk, Pinar Tasdelen, Martina Kluth, Claudia Hube‐Magg, Georgia Makrypidi‐Fraune, Katharina Möller, Doris Höflmayer, Sebastian Dwertmann Rico, Franziska Büscheck, Sarah Minner, Hans Heinzer, Markus Graefen, Andrea Hinsch, Andreas M. Luebke, David Dum, Ria Uhlig, Thorsten Schlomm, Guido Sauter, Ronald Simon, Sören A. Weidemann. High B7‐H3 expression is linked to increased risk of prostate cancer progression. Pathology International 2020; 70(10) doi: 10.1111/pin.12999
|
| 40 |
Ling Wang, Qi Zhang, Wei Chen, Baoen Shan, Yang Ding, Guochuan Zhang, Nana Cao, Lei Liu, Yingze Zhang, Pierre J. Marie. B7-H3 is Overexpressed in Patients Suffering Osteosarcoma and Associated with Tumor Aggressiveness and Metastasis. PLoS ONE 2013; 8(8) doi: 10.1371/journal.pone.0070689
|
| 41 |
Davor Babič, Ivana Jovčevska, Alja Zottel. B7-H3 in glioblastoma and beyond: significance and therapeutic strategies. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1495283
|
| 42 |
Hyunji Lee, Ji Hyun Kim, Sung Yeun Yang, Jihye Kong, Minkyung Oh, Dae Hoon Jeong, Jae-il Chung, Ki Beom Bae, Jin Yong Shin, Kwan Hee Hong, Inhak Choi. Peripheral blood gene expression of B7 and CD28 family members associated with tumor progression and microscopic lymphovascular invasion in colon cancer patients. Journal of Cancer Research and Clinical Oncology 2010; 136(9) doi: 10.1007/s00432-010-0800-4
|
| 43 |
S. Groeger, F. Denter, G. Lochnit, M. L. Schmitz, J. Meyle, Marvin Whiteley. Porphyromonas gingivalis Cell Wall Components Induce Programmed Death Ligand 1 (PD-L1) Expression on Human Oral Carcinoma Cells by a Receptor-Interacting Protein Kinase 2 (RIP2)-Dependent Mechanism. Infection and Immunity 2020; 88(5) doi: 10.1128/IAI.00051-20
|
| 44 |
APARAJITA BARAL, HONG XING YE, PU CHA JIANG, YU YAO, YING MAO. B7-H3 and B7-H1 expression in cerebral spinal fluid and tumor tissue correlates with the malignancy grade of glioma patients. Oncology Letters 2014; 8(3) doi: 10.3892/ol.2014.2268
|
| 45 |
Lorenzo Belluomini, Marco Sposito, Alice Avancini, Jessica Insolda, Michele Milella, Antonio Rossi, Sara Pilotto. Unlocking New Horizons in Small-Cell Lung Cancer Treatment: The Onset of Antibody–Drug Conjugates. Cancers 2023; 15(22) doi: 10.3390/cancers15225368
|
| 46 |
Takeshi Azuma, Yujiro Sato, Tatsukuni Ohno, Miyuki Azuma, Haruki Kume, Francisco X. Real. Serum soluble B7-H3 is a prognostic marker for patients with non-muscle-invasive bladder cancer. PLOS ONE 2020; 15(12) doi: 10.1371/journal.pone.0243379
|
| 47 |
Sai Han, Ying Wang, Xuejiao Shi, Liju Zong, Lu Liu, Juan Zhang, Qiuhong Qian, Jing Jin, Yana Ma, Baoxia Cui, Xingsheng Yang, Beihua Kong, Youzhong Zhang. Negative roles of B7-H3 and B7-H4 in the microenvironment of cervical cancer. Experimental Cell Research 2018; 371(1) doi: 10.1016/j.yexcr.2018.08.014
|
| 48 |
Meng-Yao Wang, Bin Qi, Fang Wang, Zhi-Rui Lin, Ming-Yi Li, Wen-Jing Yin, Yan-Yi Zhu, Lu He, Yi Yu, Fang Yang, Jin-Quan Liu, Dong-Ping Chen. PBK phosphorylates MSL1 to elicit epigenetic modulation of CD276 in nasopharyngeal carcinoma. Oncogenesis 2021; 10(1) doi: 10.1038/s41389-020-00293-9
|
| 49 |
N. E. Kushlinskii, O. V. Kovaleva, A. A. Alferov, Yu. B. Kuzmin, E. A. Sushentsov, I. S. Stilidi. Expression of the immune checkpoint B7-H3 in tumor and its soluble form in serum of patients with bone neoplasms. Almanac of Clinical Medicine 2021; 49(3) doi: 10.18786/2072-0505-2021-49-013
|
| 50 |
Masaaki Hashiguchi, Hiroko Kobori, Patcharee Ritprajak, Yosuke Kamimura, Haruo Kozono, Miyuki Azuma. Triggering receptor expressed on myeloid cell-like transcript 2 (TLT-2) is a counter-receptor for B7-H3 and enhances T cell responses. Proceedings of the National Academy of Sciences 2008; 105(30) doi: 10.1073/pnas.0802423105
|
| 51 |
Yishan Liu, Ljiljana Vlatkovic, Thorstein Sæter, Einar Servoll, Gudmund Waaler, Jahn M Nesland, Karl‐Erik Giercksky, Karol Axcrona. Is the clinical malignant phenotype of prostate cancer a result of a highly proliferative immune‐evasive B7‐H3‐expressing cell population?. International Journal of Urology 2012; 19(8) doi: 10.1111/j.1442-2042.2012.03017.x
|
| 52 |
Janelle M. Fauci, J. Michael Straughn, Soldano Ferrone, Donald J. Buchsbaum. A review of B7-H3 and B7-H4 immune molecules and their role in ovarian cancer. Gynecologic Oncology 2012; 127(2) doi: 10.1016/j.ygyno.2012.08.017
|
| 53 |
B Benzon, S G Zhao, M C Haffner, M Takhar, N Erho, K Yousefi, P Hurley, J L Bishop, J Tosoian, K Ghabili, M Alshalalfa, S Glavaris, B W Simons, P Tran, E Davicioni, R J Karnes, K Boudadi, E S Antonarakis, E M Schaeffer, C G Drake, F Feng, A E Ross. Correlation of B7-H3 with androgen receptor, immune pathways and poor outcome in prostate cancer: an expression-based analysis. Prostate Cancer and Prostatic Diseases 2017; 20(1) doi: 10.1038/pcan.2016.49
|
| 54 |
Vibeke Anett Ingebrigtsen, Kjetil Boye, Christina Tekle, Jahn Martin Nesland, Kjersti Flatmark, Øystein Fodstad. B7‐H3 expression in colorectal cancer: Nuclear localization strongly predicts poor outcome in colon cancer. International Journal of Cancer 2012; 131(11) doi: 10.1002/ijc.27566
|
| 55 |
Kit Kitichotkul, Nirush Lertprasertsuke, Sompid Kintarak, Surawut Pongsiriwet, Warit Powcharoen, Anak Iamaroon. . 2022; doi: 10.2139/ssrn.4143201
|
| 56 |
Jingting Jiang, Yibei Zhu, Changping Wu, Yueping Shen, Wenxiang Wei, Lujun Chen, Xiao Zheng, Jing Sun, Binfeng Lu, Xueguang Zhang. Tumor expression of B7-H4 predicts poor survival of patients suffering from gastric cancer. Cancer Immunology, Immunotherapy 2010; 59(11) doi: 10.1007/s00262-010-0900-7
|
| 57 |
Fang Cong, Haitao Yu, Xiuhua Gao. Expression of CD24 and B7-H3 in breast cancer and the clinical significance. Oncology Letters 2017; doi: 10.3892/ol.2017.7142
|
| 58 |
Dagmar Quandt, Eckhard Fiedler, Diana Boettcher, Wolfgang Ch Marsch, Barbara Seliger. B7-H4 Expression in Human Melanoma: Its Association with Patients' Survival and Antitumor Immune Response. Clinical Cancer Research 2011; 17(10) doi: 10.1158/1078-0432.CCR-10-2268
|
| 59 |
Karine Flem-Karlsen, Øystein Fodstad, Caroline E. Nunes-Xavier. B7-H3 Immune Checkpoint Protein in Human Cancer. Current Medicinal Chemistry 2020; 27(24) doi: 10.2174/0929867326666190517115515
|
| 60 |
Dongbao Li, Jun Wang, Jian Zhou, Shenghua Zhan, Yang Huang, Fei Wang, Zixiang Zhang, Dongming Zhu, Hua Zhao, Dechun Li, Gang Chen, Xinguo Zhu, Xin Zhao. B7-H3 combats apoptosis induced by chemotherapy by delivering signals to pancreatic cancer cells. Oncotarget 2017; 8(43) doi: 10.18632/oncotarget.20421
|
| 61 |
Shenghua Zhan, Zhiju Liu, Min Zhang, Tianwei Guo, Qiuying Quan, Lili Huang, Lingchuan Guo, Lei Cao, Xueguang Zhang. Overexpression of B7-H3 in α-SMA-Positive Fibroblasts Is Associated With Cancer Progression and Survival in Gastric Adenocarcinomas. Frontiers in Oncology 2020; 9 doi: 10.3389/fonc.2019.01466
|
| 62 |
Yael S. Barach, Jun Sik Lee, Xingxing Zang. T cell coinhibition in prostate cancer: new immune evasion pathways and emerging therapeutics. Trends in Molecular Medicine 2011; 17(1) doi: 10.1016/j.molmed.2010.09.006
|
| 63 |
Zhili Xu, Ling Wang, Jianhua Tian, Hongwei Man, Pengfei Li, Baoen Shan. High expression of B7-H3 and CD163 in cancer tissues indicates malignant clinicopathological status and poor prognosis of patients with urothelial cell carcinoma of the bladder. Oncology Letters 2018; doi: 10.3892/ol.2018.8173
|
| 64 |
HONG XU, XIAOLING CHEN, MIN TAO, KAI CHEN, CHEN CHEN, GANG XU, WEI LI, SUXU YUAN, YIXIANG MAO. B7-H3 and B7-H4 are independent predictors of a poor prognosis in patients with pancreatic cancer. Oncology Letters 2016; 11(3) doi: 10.3892/ol.2016.4128
|
| 65 |
Kyung H. Yi, Lieping Chen. Fine tuning the immune response through B7‐H3 and B7‐H4. Immunological Reviews 2009; 229(1) doi: 10.1111/j.1600-065X.2009.00768.x
|
| 66 |
Shuaixiang Zhao, He Zhang, Guanning Shang. Research progress of B7-H3 in malignant tumors. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1586759
|
| 67 |
S. Groeger, F. Jarzina, U. Mamat, J. Meyle. Induction of B7-H1 receptor by bacterial cells fractions of Porphyromonas gingivalis on human oral epithelial cells. Immunobiology 2017; 222(2) doi: 10.1016/j.imbio.2016.10.011
|
| 68 |
Barbara Seliger, Dagmar Quandt. The expression, function, and clinical relevance of B7 family members in cancer. Cancer Immunology, Immunotherapy 2012; 61(8) doi: 10.1007/s00262-012-1293-6
|
| 69 |
Sepideh Mirzaei, Mohammad Hossein Gholami, Mahmood Khaksary Mahabady, Noushin Nabavi, Amirhossein Zabolian, Seyed Mohammad Banihashemi, Amirabbas Haddadi, Maliheh Entezari, Kiavash Hushmandi, Pooyan Makvandi, Saeed Samarghandian, Ali Zarrabi, Milad Ashrafizadeh, Haroon Khan. Pre-clinical investigation of STAT3 pathway in bladder cancer: Paving the way for clinical translation. Biomedicine & Pharmacotherapy 2021; 133 doi: 10.1016/j.biopha.2020.111077
|
| 70 |
Alexander Sankin, Deepa Narasimhulu, Peter John, Benjamin Gartrell, Mark Schoenberg, Xingxing Zang. The expanding repertoire of targets for immune checkpoint inhibition in bladder cancer: What lies beneath the tip of the iceberg, PD-L1. Urologic Oncology: Seminars and Original Investigations 2018; 36(10) doi: 10.1016/j.urolonc.2017.04.007
|
| 71 |
Xianyun Zhang, Chuntao Fang, Guangbo Zhang, Fujin Jiang, Lei Wang, Jianquan Hou. Prognostic value of B7-H3 expression in patients with solid tumors: a meta-analysis. Oncotarget 2017; 8(54) doi: 10.18632/oncotarget.21114
|
| 72 |
Lili Huang, Yan Zhou, Qiuwei Sun, Lei Cao, Xueguang Zhang. Evaluation of the role of soluble B7-H3 in association with membrane B7-H3 expression in gastric adenocarcinoma. Cancer Biomarkers 2022; 33(1) doi: 10.3233/CBM-210178
|
| 73 |
Yangzhi Qi, Baohui Liu, Qian Sun, Xiaoxing Xiong, Qianxue Chen. Immune Checkpoint Targeted Therapy in Glioma: Status and Hopes. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.578877
|
| 74 |
Bita Amir Taghavi, Nazila Alizadeh, Hossein Saeedi, Noora Karim Ahangar, Afshin Derakhshani, Khalil Hajiasgharzadeh, Nicola Silvestris, Behzad Baradaran, Oronzo Brunetti. Targeted Therapy of B7 Family Checkpoints as an Innovative Approach to Overcome Cancer Therapy Resistance: A Review from Chemotherapy to Immunotherapy. Molecules 2022; 27(11) doi: 10.3390/molecules27113545
|
| 75 |
Martin Loos, Dennis M. Hedderich, Helmut Friess, Jörg Kleeff, C. D. Pauza. B7‐H3 and Its Role in Antitumor Immunity. Journal of Immunology Research 2010; 2010(1) doi: 10.1155/2010/683875
|
| 76 |
N. Maeda, K. Yoshimura, S. Yamamoto, A. Kuramasu, M. Inoue, N. Suzuki, Y. Watanabe, Y. Maeda, R. Kamei, R. Tsunedomi, Y. Shindo, M. Inui, K. Tamada, S. Yoshino, S. Hazama, M. Oka. Expression of B7-H3, a Potential Factor of Tumor Immune Evasion in Combination with the Number of Regulatory T Cells, Affects Against Recurrence-Free Survival in Breast Cancer Patients. Annals of Surgical Oncology 2014; 21(S4) doi: 10.1245/s10434-014-3564-2
|
| 77 |
Nadia Bolandi, Afshin Derakhshani, Nima Hemmat, Amir Baghbanzadeh, Zahra Asadzadeh, Mina Afrashteh Nour, Oronzo Brunetti, Renato Bernardini, Nicola Silvestris, Behzad Baradaran. The Positive and Negative Immunoregulatory Role of B7 Family: Promising Novel Targets in Gastric Cancer Treatment. International Journal of Molecular Sciences 2021; 22(19) doi: 10.3390/ijms221910719
|
| 78 |
Siji Chen, Shenghua Zhan, Sisi Ding, Qiange Zhang, Hanqin Xuan, Xueguang Zhang, Lei Cao. B7-H3 and CD47 co-expression in gastric cancer is a predictor of poor prognosis and potential targets for future dual-targeting immunotherapy. Journal of Cancer Research and Clinical Oncology 2023; 149(18) doi: 10.1007/s00432-023-05408-4
|
| 79 |
Biology of T Cells - Part A. International Review of Cell and Molecular Biology 2018; 341 doi: 10.1016/bs.ircmb.2018.05.010
|
| 80 |
R Houston Thompson, Eugene D Kwon, James P Allison. Inhibitors of B7–CD28 Costimulation in Urologic Malignancies. Immunotherapy 2009; 1(1) doi: 10.2217/1750743X.1.1.129
|
| 81 |
Sabine Groeger, Joerg Meyle. The role of programmed death receptor (PD‐)1/PD‐ligand (L)1 in periodontitis and cancer. Periodontology 2000 2024; 96(1) doi: 10.1111/prd.12548
|
| 82 |
ZHENXIN WANG, JIANFENG YANG, YANBO ZHU, YUN ZHU, BIN ZHANG, YINGHUI ZHOU. Differential expression of 2IgB7-H3 and 4IgB7-H3 in cancer cell lines and glioma tissues. Oncology Letters 2015; 10(4) doi: 10.3892/ol.2015.3611
|
| 83 |
Murali Janakiram, Urvi A. Shah, Weifeng Liu, Aimin Zhao, Mark P. Schoenberg, Xingxing Zang. The third group of the B7‐CD28 immune checkpoint family: HHLA2, TMIGD2, B7x, and B7‐H3. Immunological Reviews 2017; 276(1) doi: 10.1111/imr.12521
|
| 84 |
Qiuzhi Gao, Linjing Cui, Chao Huang, Zhihong Chen, Xin Wang, Shaodi Wen, Yuanyuan Zhao, Mei Wang, Bo Shen, Wei Zhu. Gastric cancer-derived mesenchymal stem cells promote gastric cancer cell lines migration by modulating CD276 expression. Experimental Cell Research 2023; 422(1) doi: 10.1016/j.yexcr.2022.113414
|
| 85 |
Binghao Zhao, Huanzhang Li, Yu Xia, Yaning Wang, Yuekun Wang, Yixin Shi, Hao Xing, Tian Qu, Yu Wang, Wenbin Ma. Immune checkpoint of B7-H3 in cancer: from immunology to clinical immunotherapy. Journal of Hematology & Oncology 2022; 15(1) doi: 10.1186/s13045-022-01364-7
|
| 86 |
Liyun Zhou, Zhenhua Jiang, Jing Gu, Wenhui Gu, Shuangyin Han. B7-H3 and digestive system cancers. European Journal of Inflammation 2021; 19 doi: 10.1177/20587392211000581
|
| 87 |
Federico Pio Fabrizio, Lucia Anna Muscarella, Antonio Rossi. B7-H3/CD276 and small-cell lung cancer: What's new?. Translational Oncology 2024; 39 doi: 10.1016/j.tranon.2023.101801
|
| 88 |
Chaojie Zhai, Jiarong Ye, Xiaoyan Li, Jipeng Liu, Xinchi Zhou, Zuao Wang, Xu Zhang, Wen Zeng, Hongliang Luo, Leifeng Chen, Fan Zhou. From mechanism to clinical: research evolution and hotspot analysis of CD276/B7-H3 in cancer immunotherapy. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1751400
|
| 89 |
Hexing Yuan, Xuedong Wei, Guangbo Zhang, Chen Li, Xueguang Zhang, Jianquan Hou. B7-H3 Over Expression in Prostate Cancer Promotes Tumor Cell Progression. Journal of Urology 2011; 186(3) doi: 10.1016/j.juro.2011.04.103
|
| 90 |
Mahiuddin Ahmed, Ming Cheng, Qi Zhao, Yehuda Goldgur, Sarah M. Cheal, Hong-Fen Guo, Steven M. Larson, Nai-Kong V. Cheung. Humanized Affinity-matured Monoclonal Antibody 8H9 Has Potent Antitumor Activity and Binds to FG Loop of Tumor Antigen B7-H3. Journal of Biological Chemistry 2015; 290(50) doi: 10.1074/jbc.M115.679852
|
| 91 |
Lei Cai, Theodoros Michelakos, Vikram Deshpande, Kshitij S. Arora, Teppei Yamada, David T. Ting, Marty S. Taylor, Carlos Fernandez-del Castillo, Andrew L. Warshaw, Keith D. Lillemoe, Soldano Ferrone, Cristina R. Ferrone. Role of Tumor-Associated Macrophages in the Clinical Course of Pancreatic Neuroendocrine Tumors (PanNETs). Clinical Cancer Research 2019; 25(8) doi: 10.1158/1078-0432.CCR-18-1401
|
| 92 |
Danzan Mansorunov, Natalya Apanovich, Pavel Apanovich, Fatimat Kipkeeva, Tatyana Muzaffarova, Anna Kuzevanova, Maxim Nikulin, Olga Malikhova, Alexander Karpukhin. Expression of Immune Checkpoints in Malignant Tumors: Therapy Targets and Biomarkers for the Gastric Cancer Prognosis. Diagnostics 2021; 11(12) doi: 10.3390/diagnostics11122370
|
| 93 |
Takaaki Arigami, Yoshikazu Uenosono, Munetsugu Hirata, Shigehiro Yanagita, Sumiya Ishigami, Shoji Natsugoe. B7‐H3 expression in gastric cancer: A novel molecular blood marker for detecting circulating tumor cells. Cancer Science 2011; 102(5) doi: 10.1111/j.1349-7006.2011.01877.x
|
| 94 |
RD Coletta, AFP Leme. B7‐H3 overexpression in oral cancer. Oral Diseases 2016; 22(3) doi: 10.1111/odi.12413
|
| 95 |
Hiroko Kobori, Masaaki Hashiguchi, Jinhua Piao, Moriyuki Kato, Patcharee Ritprajak, Miyuki Azuma. Enhancement of effector CD8+ T‐cell function by tumour‐associated B7‐H3 and modulation of its counter‐receptor triggering receptor expressed on myeloid cell‐like transcript 2 at tumour sites. Immunology 2010; 130(3) doi: 10.1111/j.1365-2567.2009.03236.x
|
| 96 |
Ling Ni, Chen Dong. New checkpoints in cancer immunotherapy. Immunological Reviews 2017; 276(1) doi: 10.1111/imr.12524
|
| 97 |
Ali Safarzadeh, Mohsen Alizadeh, Fatemeh Beyranvand, Reza Falavand Jozaaee, Khalil Hajiasgharzadeh, Amir Baghbanzadeh, Afshin Derakhshani, Antonella Argentiero, Behzad Baradaran, Nicola Silvestris. Varied functions of immune checkpoints during cancer metastasis. Cancer Immunology, Immunotherapy 2021; 70(3) doi: 10.1007/s00262-020-02717-2
|
| 98 |
Ling‐yi Zhang, Ye Jin, Pei‐hui Xia, Jiang Lin, Ji‐chun Ma, Ting Li, Zi‐qi Liu, He‐lin Xiang, Chen Cheng, Zi‐jun Xu, Hong Zhou, Jun Qian. Integrated analysis reveals distinct molecular, clinical, and immunological features of B7‐H3 in acute myeloid leukemia. Cancer Medicine 2021; 10(21) doi: 10.1002/cam4.4284
|
| 99 |
Phyu P. Aung, Edwin Roger Parra, Souptik Barua, Dawen Sui, Jing Ning, Barbara Mino, Debora Alejandra Ledesma, Jonathan L. Curry, Priyadharsini Nagarajan, Carlos A. Torres-Cabala, Eleni Efstathiou, Anh G. Hoang, Michael K. Wong, Jennifer A. Wargo, Alexander J. Lazar, Arvind Rao, Victor G. Prieto, Ignacio Wistuba, Michael T. Tetzlaff. B7-H3 Expression in Merkel Cell Carcinoma–Associated Endothelial Cells Correlates with Locally Aggressive Primary Tumor Features and Increased Vascular Density. Clinical Cancer Research 2019; 25(11) doi: 10.1158/1078-0432.CCR-18-2355
|
| 100 |
XIN ZHAO, DE-CHUN LI, XIN-GUO ZHU, WEN-JUAN GAN, ZHI LI, FENG XIONG, ZI-XIANG ZHANG, GUANG-BO ZHANG, XUE-GUANG ZHANG, HUA ZHAO. B7-H3 overexpression in pancreatic cancer promotes tumor progression. International Journal of Molecular Medicine 2013; 31(2) doi: 10.3892/ijmm.2012.1212
|
| 101 |
Christian A Petrulio, Seunghee Kim-Schulze, Howard L Kaufman. The tumour microenvironment and implications for cancer immunotherapy. Expert Opinion on Biological Therapy 2006; 6(7) doi: 10.1517/14712598.6.7.671
|
| 102 |
Ling Wang, Fu‐Biao Kang, Bao‐En Shan. B7‐H3‐mediated tumor immunology: Friend or foe?. International Journal of Cancer 2014; 134(12) doi: 10.1002/ijc.28474
|
| 103 |
Liang Lin, Li Cao, Yang Liu, Ke Wang, Xinwei Zhang, Xiaodan Qin, Dandan Zhao, Jie Hao, Yingjun Chang, Xiaojun Huang, Bei Liu, Jun Zhang, Jin Lu, Qing Ge. B7-H3 promotes multiple myeloma cell survival and proliferation by ROS-dependent activation of Src/STAT3 and c-Cbl-mediated degradation of SOCS3. Leukemia 2019; 33(6) doi: 10.1038/s41375-018-0331-6
|
| 104 |
Andrew J.S. Furness, Frederick Arce Vargas, Karl S. Peggs, Sergio A. Quezada. Impact of tumour microenvironment and Fc receptors on the activity of immunomodulatory antibodies. Trends in Immunology 2014; 35(7) doi: 10.1016/j.it.2014.05.002
|
| 105 |
JIAN SHI, DONG-LEI ZHANG, ZHI-CHU CUI, HUI-MIN WANG. Preparation and application of a novel monoclonal antibody specific for human B7-H3. Molecular Medicine Reports 2016; 14(1) doi: 10.3892/mmr.2016.5288
|
| 106 |
Lingchuan Guo, Zhiju Liu, Yun Zhang, Qiuying Quan, Lili Huang, Yunyun Xu, Lei Cao, Xueguang Zhang. Association of increased B7 protein expression by infiltrating immune cells with progression of gastric carcinogenesis. Medicine 2019; 98(8) doi: 10.1097/MD.0000000000014663
|
| 107 |
Theodoros Michelakos, Filippos Kontos, Omar Barakat, Luke Maggs, Joseph H. Schwab, Cristina R. Ferrone, Soldano Ferrone. B7-H3 targeted antibody-based immunotherapy of malignant diseases. Expert Opinion on Biological Therapy 2021; 21(5) doi: 10.1080/14712598.2021.1862791
|
| 108 |
Han Yan, Wanglong Qiu, Anne K. Koehne de Gonzalez, Ji-Shu Wei, Min Tu, Chun-Hua Xi, Ye-Ran Yang, Yun-Peng Peng, Wei-Yann Tsai, Helen E. Remotti, Yi Miao, Gloria H. Su. HHLA2 is a novel immune checkpoint protein in pancreatic ductal adenocarcinoma and predicts post-surgical survival. Cancer Letters 2019; 442 doi: 10.1016/j.canlet.2018.11.007
|
| 109 |
Xingxing Zang, R. Houston Thompson, Hikmat A. Al-Ahmadie, Angel M. Serio, Victor E. Reuter, James A. Eastham, Peter T. Scardino, Padmanee Sharma, James P. Allison. B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome. Proceedings of the National Academy of Sciences 2007; 104(49) doi: 10.1073/pnas.0709802104
|
| 110 |
Dallas B. Flies, Lieping Chen. The New B7s: Playing a Pivotal Role in Tumor Immunity. Journal of Immunotherapy 2007; 30(3) doi: 10.1097/CJI.0b013e31802e085a
|
| 111 |
Jung-Tsu Chen, Chein-Hung Chen, Ko-Li Ku, Michael Hsiao, Chun-Pin Chiang, Tsui-Ling Hsu, Min-Huey Chen, Chi-Huey Wong. Glycoprotein B7-H3 overexpression and aberrant glycosylation in oral cancer and immune response. Proceedings of the National Academy of Sciences 2015; 112(42) doi: 10.1073/pnas.1516991112
|
| 112 |
Yan-Han Xu, Peng Lu, Ming-Cheng Gao, Rui Wang, Yang-Yang Li, Rong-Qi Guo, Wei-Song Zhang, Jian-Xiang Song. Nomogram based on multimodal magnetic resonance combined with B7-H3mRNA for preoperative lymph node prediction in esophagus cancer. World Journal of Clinical Oncology 2024; 15(3): 419-433 doi: 10.5306/wjco.v15.i3.419
|
| 113 |
Kathleen M. Mahoney, Paul D. Rennert, Gordon J. Freeman. Combination cancer immunotherapy and new immunomodulatory targets. Nature Reviews Drug Discovery 2015; 14(8) doi: 10.1038/nrd4591
|
| 114 |
Filippos Kontos, Theodoros Michelakos, Tomohiro Kurokawa, Ananthan Sadagopan, Joseph H. Schwab, Cristina R. Ferrone, Soldano Ferrone. B7-H3: An Attractive Target for Antibody-based Immunotherapy. Clinical Cancer Research 2021; 27(5) doi: 10.1158/1078-0432.CCR-20-2584
|
| 115 |
Timothy J. Roth, Yuri Sheinin, Christine M. Lohse, Susan M. Kuntz, Xavier Frigola, Brant A. Inman, Amy E. Krambeck, Maureen E. Mckenney, R. Jeffrey Karnes, Michael L. Blute, John C. Cheville, Thomas J. Sebo, Eugene D. Kwon. B7-H3 Ligand Expression by Prostate Cancer: A Novel Marker of Prognosis and Potential Target for Therapy. Cancer Research 2007; 67(16) doi: 10.1158/0008-5472.CAN-07-1068
|
| 116 |
Sunitha V. Bachawal, Kristin C. Jensen, Katheryne E. Wilson, Lu Tian, Amelie M. Lutz, Jürgen K. Willmann. Breast Cancer Detection by B7-H3–Targeted Ultrasound Molecular Imaging. Cancer Research 2015; 75(12) doi: 10.1158/0008-5472.CAN-14-3361
|
| 117 |
Petar Rasic, Maja Jovanovic-Tucovic, Marija Jeremic, Slavisa M Djuricic, Zorica V Vasiljevic, Maja Milickovic, Djordje Savic. B7 homologue 3 as a prognostic biomarker and potential therapeutic target in gastrointestinal tumors. World Journal of Gastrointestinal Oncology 2021; 13(8): 799-821 doi: 10.4251/wjgo.v13.i8.799
|
| 118 |
Yixuan Li, Qian Cai, Ximing Shen, Xiaoting Chen, Zhong Guan. Overexpression of B7-H3 Is Associated With Poor Prognosis in Laryngeal Cancer. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.759528
|
| 119 |
Zhou Bin, Zhang Guangbo, Ge Yan, Zhou Huan, Lv Desheng, Zhang Xueguang. Overexpression of B7-H3 in CD133+ colorectal cancer cells is associated with cancer progression and survival in human patients. Journal of Surgical Research 2014; 188(2) doi: 10.1016/j.jss.2014.01.014
|
| 120 |
Amy K. Kim, Faiz Gani, Andrew J. Layman, Sepideh Besharati, Qingfeng Zhu, Farah Succaria, Elizabeth L. Engle, Feriyl Bhaijee, Maria B. Goggins, Nicolas J. Llosa, Timothy M. Pawlik, Mark Yarchoan, Elizabeth M. Jaffee, Howard C. Simons, Janis M. Taube, Robert A. Anders. Multiple Immune-Suppressive Mechanisms in Fibrolamellar Carcinoma. Cancer Immunology Research 2019; 7(5) doi: 10.1158/2326-6066.CIR-18-0499
|
| 121 |
A. I. Chapoval, S. P. Chapoval, N. S. Shcherbakova, D. N. Shcherbakov. Immune Checkpoints of the B7 Family. Part 2. Representatives of the B7 Family B7-H3, B7-H4, B7-H5, B7-H6, B7-H7, and ILDR2 and Their Receptors. Russian Journal of Bioorganic Chemistry 2019; 45(5) doi: 10.1134/S1068162019050091
|